
The sterile promise of a high-tech hospital environment often masks the persistent threat of microscopic airborne pathogens that can prove lethal to the most vulnerable patients during periods of structural redevelopment. Managing these clinical environments within major metropolitan health districts requires a delicate balance between modernizing facilities and maintaining strict biosecurity. For immunocompromised individuals in high-risk zones like transplant wards,










